ESTABLISHMENT OF ASSAY KITS FOR THE DETERMINATION OF MICROHETEROGENEITIES OF ALPHA-FETOPROTEIN USING LECTIN-AFFINITY ELECTROPHORESIS

被引:71
作者
SHIMIZU, K
TANIICHI, T
SATOMURA, S
MATSUURA, S
TAGA, H
TAKETA, K
机构
[1] WAKO PURE CHEM IND LTD,OSAKA RES LAB,6-1 TAKADA CHO,AMAGASAKI,HYOGO 661,JAPAN
[2] OKAYAMA UNIV,SCH MED,DEPT PUBL HLTH,OKAYAMA 700,JAPAN
关键词
ALPHA-FETOPROTEIN; CARBOHYDRATE CHAIN; TUMOR MARKER; LECTIN ELECTROPHORESIS; HEPATOCELLULAR CARCINOMA; LENS-CULINARIS AGGLUTININ-A; ERYTHRO-AGGLUTINATING PHYTOHEMAGGLUTININ-E4;
D O I
10.1016/0009-8981(93)90297-H
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Diagnostic kits for determination of alpha-fetoprotein (AFP) carbohydrate chain microheterogeneity were developed using lectin affinity electrophoresis with Lens culinaris agglutinin-A (LCA-A) and erythro-agglutinating phytohemagglutinin-E4 (PHA-E4). Separated AFP bands by electrophoresis were detected with high sensitivity by antibody-affinity blotting and immunoenzymatic amplification. Densitometry was used to apportion lectin reactive AFPs. The within-run S.D. for proportions of AFP bands was below 3%. Band intensity was linearly related to AFP concentration between 2 and 200 ng/ml. Profiles of lectin reactive AFPs were compared in serum samples from 55 patients having liver diseases. The average values of lectin reactive AFPs for chronic hepatitis and liver cirrhosis patients were both below 13%, but those of hepatocellular carcinoma patients were above 25%. Correlation of data with disease states suggests that the methods can greatly facilitate the discrimination between benign and malignant liver diseases.
引用
收藏
页码:3 / 12
页数:10
相关论文
共 23 条
[1]  
ABELEV GI, 1968, CANCER RES, V28, P1344
[2]   SERUM ALPHA-FETOPROTEIN (AFP) IN BENIGN AND MALIGNANT GASTROINTESTINAL DISEASES - EVALUATION OF AN IMMUNOENZYMATIC ASSAY [J].
ALPERT, E ;
COSTON, RL .
CLINICA CHIMICA ACTA, 1975, 58 (01) :77-83
[3]   ALPHA1 FETOGLOBULIN IN DIAGNOSIS OF HUMAN HEPATOMA [J].
ALPERT, ME ;
URIEL, J ;
DENECHAU.B .
NEW ENGLAND JOURNAL OF MEDICINE, 1968, 278 (18) :984-&
[4]  
AOYAGI Y, 1988, CANCER-AM CANCER SOC, V61, P769, DOI 10.1002/1097-0142(19880215)61:4<769::AID-CNCR2820610422>3.0.CO
[5]  
2-M
[6]   ALPHA-FETOPROTEIN IN NON-NEOPLASTIC HEPATIC DISORDERS [J].
BLOOMER, JR ;
WALDMANN, TA ;
MCINTIRE, KR ;
KLATSKIN, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1975, 233 (01) :38-41
[7]   MICROHETEROGENEITY OF ALPHA-FETOPROTEIN IN PATIENT SERUM AS DEMONSTRATED BY LECTIN AFFINO-ELECTROPHORESIS [J].
BREBOROWICZ, J ;
MACKIEWICZ, A ;
BREBOROWICZ, D .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1981, 14 (01) :15-20
[8]  
KERCKAERT JP, 1979, BIOCHIM BIOPHYS ACTA, V576, P99, DOI 10.1016/0005-2795(79)90488-4
[9]   ALPHA-FETOPROTEIN ANTIBODY-LECTIN ENZYME-IMMUNOASSAY TO CHARACTERIZE SUGAR CHAINS FOR THE STUDY OF LIVER-DISEASES [J].
KINOSHITA, N ;
SUZUKI, S ;
MATSUDA, Y ;
TANIGUCHI, N .
CLINICA CHIMICA ACTA, 1989, 179 (02) :143-152
[10]  
NAKABAYASHI H, 1982, CANCER RES, V42, P3858